(Q47323112)

English

Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer.

scientific article published in October 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/16948128

Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer. (English)

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/16948128

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/16948128

Suzette Delaloge

4

object named as

Suzette Delaloge

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/16948128

5

object named as

Kelly K Hunt

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/16948128

Gabriel N Hortobagyi

6

object named as

Gabriel N Hortobagyi

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/16948128

author name string

Lajos Pusztai

2

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/16948128

Jean-Remi Garbay

3

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/16948128

Donald Berry

7

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/16948128

Henry M Kuerer

8

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/16948128

language of work or name

0 references

publication date

1 October 2006

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/16948128

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/16948128

107

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/16948128

1459-1466

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/16948128

7

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/16948128

Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, Pennsylvania

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22177

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22177

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22177

7 January 2021

based on heuristic

inferred from DOI database lookup

A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22177

7 January 2021

based on heuristic

inferred from DOI database lookup

Nomograms as predictive models

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22177

7 January 2021

based on heuristic

inferred from DOI database lookup

A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22177

7 January 2021

based on heuristic

inferred from DOI database lookup

A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22177

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary chemotherapy in the treatment of breast cancer: the University of Texas M. D. Anderson Cancer Center experience.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22177

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22177

7 January 2021

based on heuristic

inferred from DOI database lookup

The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22177

7 January 2021

based on heuristic

inferred from DOI database lookup

Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22177

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22177

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast surgery in the 'Arimidex, Tamoxifen Alone or in Combination' (ATAC) trial: American women are more likely than women from the United Kingdom to undergo mastectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22177

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized parallel study of doxorubicin plus paclitaxel and doxorubicin plus cyclophosphamide as neoadjuvant treatment of patients with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22177

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22177

7 January 2021

based on heuristic

inferred from DOI database lookup

Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22177

7 January 2021

based on heuristic

inferred from DOI database lookup

Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22177

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.22177

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/16948128

1 reference

Europe PubMed Central

14 January 2018

http://europepmc.org/abstract/MED/16948128

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47323112&oldid=1768743864"